Screener
Charles River Laboratories CRL Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$760K-101% | -$14.8M-157% | -$276.29M— | $55.56M-21.0% | $52.69M-44.1% | ||
| $67.29M-43.7% | $67.15M-44.2% | $78.28M-23.3% | $85.16M-3.4% | $119.51M+38.8% | ||
| $19.78M+16.0% | $22.38M+70.4% | $17.63M+2.3% | $23.27M+20.4% | $17.05M+2.8% | ||
| $179.73M-12.2% | $41.08M-76.1% | $147.52M-7.4% | $213.83M-15.1% | $204.6M+5.7% | ||
| $31.11M-11.9% | $55.91M-5.8% | $88.95M+17.6% | $35.58M-8.1% | $35.3M-10.6% | ||
| $62.25M— | $405.01M— | $0— | $0— | $0-100% | ||
| —— | -$407.85M-797% | -$92.81M-21.9% | -$33.7M-58.0% | -$37.34M+39.6% | ||
| $115.6M+1,472% | $208.29M-41.0% | $96K-22.6% | $93K-99.9% | $7.35M-17.5% | ||
| $352.8M-35.5% | $912.46M+119% | $156.67M+49.5% | $107.5M-54.4% | $547.02M+24.2% | ||
| $390.25M-47.1% | $355.68M+138% | $207.82M+17.6% | $253.79M-23.0% | $738.31M+6.3% | ||
| —— | $347.72M+430% | -$51.86M+31.6% | -$152.62M+26.5% | -$226.92M+20.6% | ||
| $42.38M+190% | -$17.8M-168% | $6.78M+212% | $24.48M— | -$46.99M+70.2% | ||
| $148.62M-12.2% | -$14.83M-113% | $58.57M-30.1% | $178.25M-16.3% | $169.31M+9.9% |
FAQ
- How much cash does Charles River Laboratories generate?
- Charles River Laboratories (CRL) generated $582.1M in operating cash flow over the trailing twelve months.
- What is Charles River Laboratories's free cash flow?
- After $211.5M of capital expenditures, Charles River Laboratories's free cash flow was $370.6M over the trailing twelve months, down 35.9% year over year.
- Where does Charles River Laboratories's cash flow data come from?
- Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
